Pharmaceutical
Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)-H-C-1206-P46-0033
Advanced pharmaceutical formulation for targeted therapeutic intervention.